[HTML][HTML] B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells
M Mahévas, P Patin, F Huetz… - The Journal of …, 2012 - Am Soc Clin Investig
Primary immune thrombocytopenia (ITP) is a disorder caused by autoantibody-mediated
platelet destruction and decreased platelet production. Rituximab, a B cell–depleting agent …
platelet destruction and decreased platelet production. Rituximab, a B cell–depleting agent …
B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells.
M Mahévas, P Patin, F Huetz, M Descatoire… - Journal of Clinical …, 2013 - hal.science
Primary immune thrombocytopenia (ITP) is a disorder caused by autoantibody-mediated
platelet destruction and decreased platelet production. Rituximab, a B cell-depleting agent …
platelet destruction and decreased platelet production. Rituximab, a B cell-depleting agent …
[PDF][PDF] B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells
M Mahévas, P Patin, F Huetz, M Descatoire, N Cagnard… - researchgate.net
Primary immune thrombocytopenia (ITP) is a disorder caused by autoantibody-mediated
platelet destruction and decreased platelet production. Rituximab, a B cell–depleting agent …
platelet destruction and decreased platelet production. Rituximab, a B cell–depleting agent …
[HTML][HTML] B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells
M Mahévas, P Patin, F Huetz, M Descatoire… - The Journal of …, 2013 - ncbi.nlm.nih.gov
Primary immune thrombocytopenia (ITP) is a disorder caused by autoantibody-mediated
platelet destruction and decreased platelet production. Rituximab, a B cell–depleting agent …
platelet destruction and decreased platelet production. Rituximab, a B cell–depleting agent …
B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells.
M Mahévas, P Patin, F Huetz… - Journal of Clinical …, 2013 - search.ebscohost.com
Primary immune thrombocytopenia (ITP) is a disorder caused by autoantibody-mediated
platelet destruction and decreased platelet production. Rituximab, a B cell-depleting agent …
platelet destruction and decreased platelet production. Rituximab, a B cell-depleting agent …
[PDF][PDF] B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells.
M Mahévas, P Patin, F Huetz, M Descatoire, N Cagnard… - core.ac.uk
Primary immune thrombocytopenia (ITP) is a disorder caused by autoantibody-mediated
platelet destruction and decreased platelet production. Rituximab, a B cell–depleting agent …
platelet destruction and decreased platelet production. Rituximab, a B cell–depleting agent …
B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells
M Mahévas, P Patin, F Huetz… - The Journal of …, 2013 - pubmed.ncbi.nlm.nih.gov
Primary immune thrombocytopenia (ITP) is a disorder caused by autoantibody-mediated
platelet destruction and decreased platelet production. Rituximab, a B cell-depleting agent …
platelet destruction and decreased platelet production. Rituximab, a B cell-depleting agent …
[PDF][PDF] B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells
M Mahévas, P Patin, F Huetz, M Descatoire, N Cagnard… - Am Soc Clin Investig
Primary immune thrombocytopenia (ITP) is a disorder caused by autoantibody-mediated
platelet destruction and decreased platelet production. Rituximab, a B cell–depleting agent …
platelet destruction and decreased platelet production. Rituximab, a B cell–depleting agent …
B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells.
M Mahévas, P Patin, F Huetz… - Journal of Clinical …, 2013 - inserm.hal.science
Primary immune thrombocytopenia (ITP) is a disorder caused by autoantibody-mediated
platelet destruction and decreased platelet production. Rituximab, a B cell-depleting agent …
platelet destruction and decreased platelet production. Rituximab, a B cell-depleting agent …
B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells
M Mahevas, P Patin, F Huetz, M Descatoire… - Journal of Clinical …, 2013 - go.gale.com
Primary immune thrombocytopenia (ITP) is a disorder caused by autoantibody-mediated
platelet destruction and decreased platelet production. Rituximab, a B cell--depleting agent …
platelet destruction and decreased platelet production. Rituximab, a B cell--depleting agent …